IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 252 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,852,971 | +22.6% | 1,521,628 | +2.6% | 0.01% | +25.0% |
| Q3 2022 | $15,371,899 | -7.3% | 1,483,774 | +3.2% | 0.00% | 0.0% |
| Q2 2022 | $16,577,073 | -56.8% | 1,437,734 | -52.9% | 0.00% | -50.0% |
| Q1 2022 | $38,390,650 | +9.2% | 3,051,721 | +1.2% | 0.01% | +14.3% |
| Q4 2021 | $35,170,000 | +51.7% | 3,016,328 | +69.9% | 0.01% | +40.0% |
| Q3 2021 | $23,187,000 | +1.1% | 1,775,428 | -0.4% | 0.01% | 0.0% |
| Q2 2021 | $22,934,000 | +13.5% | 1,781,953 | -1.4% | 0.01% | 0.0% |
| Q1 2021 | $20,209,000 | -13.6% | 1,807,569 | -11.9% | 0.01% | 0.0% |
| Q4 2020 | $23,377,000 | +26.6% | 2,052,390 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $18,461,000 | -27.6% | 2,052,390 | -17.0% | 0.01% | -28.6% |
| Q2 2020 | $25,511,000 | +0.5% | 2,471,979 | -1.7% | 0.01% | -22.2% |
| Q1 2020 | $25,385,000 | -26.0% | 2,515,848 | -2.4% | 0.01% | -10.0% |
| Q4 2019 | $34,301,000 | +55.0% | 2,577,122 | 0.0% | 0.01% | +42.9% |
| Q3 2019 | $22,125,000 | -16.8% | 2,577,122 | +6.0% | 0.01% | -12.5% |
| Q2 2019 | $26,598,000 | -5.3% | 2,431,240 | +17.1% | 0.01% | -11.1% |
| Q1 2019 | $28,092,000 | +43.6% | 2,076,243 | +9.9% | 0.01% | +28.6% |
| Q4 2018 | $19,568,000 | -26.5% | 1,888,809 | +31.0% | 0.01% | -22.2% |
| Q3 2018 | $26,620,000 | +24.5% | 1,441,994 | +29.0% | 0.01% | +28.6% |
| Q2 2018 | $21,373,000 | +38.1% | 1,117,833 | +11.4% | 0.01% | +16.7% |
| Q1 2018 | $15,477,000 | -56.1% | 1,003,056 | -57.3% | 0.01% | -53.8% |
| Q4 2017 | $35,232,000 | +11.0% | 2,350,397 | +16.7% | 0.01% | +8.3% |
| Q3 2017 | $31,751,000 | -23.3% | 2,013,390 | -8.1% | 0.01% | -25.0% |
| Q2 2017 | $41,382,000 | +51.2% | 2,191,837 | +36.6% | 0.02% | +45.5% |
| Q1 2017 | $27,369,000 | +49.7% | 1,604,304 | +34.2% | 0.01% | +37.5% |
| Q4 2016 | $18,285,000 | +13.7% | 1,195,876 | +12.8% | 0.01% | 0.0% |
| Q3 2016 | $16,085,000 | +62.6% | 1,060,542 | +40.1% | 0.01% | +60.0% |
| Q2 2016 | $9,894,000 | +21.7% | 756,734 | +1.8% | 0.01% | +25.0% |
| Q1 2016 | $8,130,000 | -20.8% | 743,134 | -16.1% | 0.00% | -20.0% |
| Q4 2015 | $10,266,000 | +27.2% | 885,738 | +14.4% | 0.01% | +25.0% |
| Q3 2015 | $8,069,000 | -35.0% | 774,338 | -24.7% | 0.00% | -33.3% |
| Q2 2015 | $12,406,000 | -24.6% | 1,028,680 | 0.0% | 0.01% | -25.0% |
| Q1 2015 | $16,459,000 | +1186.9% | 1,028,680 | +1132.0% | 0.01% | +700.0% |
| Q4 2014 | $1,279,000 | -81.9% | 83,500 | -85.4% | 0.00% | -75.0% |
| Q1 2014 | $7,064,000 | -29.3% | 573,338 | -33.4% | 0.00% | -33.3% |
| Q4 2013 | $9,991,000 | -2.0% | 860,512 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $10,197,000 | – | 860,512 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |